TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/25 16:03 | 9/22/25 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | P | 434 | 2.78 | 0 | 156 | 33 | 622 | D | |||||||||||||||
8/13/25 19:48 | 8/13/25 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 4 | 4 | P | 369 | 1.34 | 0 | 275 | 45 | 886 | D | ||||||||||||||
8/4/25 16:40 | 7/31/25 | NRC | National Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 44 | 13.44 | 0 | 3 | 10 | 36 | D | ||||||||||||||
5/15/25 16:02 | 3/21/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 5 | P | 480 | 1.92 | 0 | 250 | 9 | 3,015 | D | ||||||||||||||
2/28/25 16:39 | 2/27/25 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1 | 326.00 | 0 | 0 | 0 | 13 | D | ||||||||||||||
2/21/25 16:41 | 2/20/25 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 1,252 | 164.93 | 0 | 8 | 3 | 306 | D | |||||||||||||||
2/7/25 19:03 | 12/3/24 | IQV | Iqvia Holdings Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P.d | 256 | 200.58 | 0 | 1 | 5 | 29 | I | ||||||||||||||
12/23/24 21:47 | 12/19/24 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | 4 | 5 | P | 728 | 4.26 | 0 | 171 | 63 | 442 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |